Search keyWord :

Ridgewood Infrastructure Announces Acquisition of Valley Cold

Dec 4, 2024

NEW YORK,Dec. 3,2024-- Ridgewood Infrastructure,a leading investment firm focused on essential infrastructure in the U.S. lower middle market,today announced its investment in Valley Cold Storage &am

A New Hope for Atrial Fibrillation Patients with Breakthrough Catheter Technology

Dec 4, 2024

BTL,a leader in medical innovation,is proud to announce a major milestone: the successful treatment of the first patients suffering from atrial fibrillation (AF) in a groundbreaking study using a next

CNEY Receives NASDAQ Minimum Bid Price Requirement Extension

Dec 4, 2024

LISHUI,China,Dec. 4,2024-- CN Energy Group. Inc. (NASDAQ:CNEY) ("CNEY" or the "Company") today announced that on November 26,2024,the Company received a written notice from the Lis

Half of Australians live with chronic health conditions, over a third forced to leave their jobs as a result

Dec 4, 2024

Patient advocates call for more support for Australian workers living with a chronic condition/s following therelease of anew insights report

Dunxin Financial Holdings Limited Announces Planned ADS Ratio Change

Dec 4, 2024

HONG KONG,Dec. 4,2024--Dunxin Financial Holdings Limited ("Dunxin" or the "Company") (OTC Pink: DXFFY),a company engaged in real estate operation management and investment and a di

Asia's Transformative Era: Unveiling the "Asian Dream" through New Study "Truth About Ascending Asia"

Dec 4, 2024

SINGAPORE,Dec. 4,2024-- McCann Worldgroup has launched its latest insights study,the Truth about Ascending Asia,at an event held at Singapore\'s Asian Civilisations Museum. Over 70 clients,partners an

OMNICOM MEDIA GROUP TOPS COMVERGENCE Q1-Q3 REPORT WITH $7.37 BILLION IN TOTAL NEW BUSINESS

Dec 4, 2024

In a Pitch Cycle That Saw 50% Churn Rate,OMG Is #1 for Retention,Holding on to 85% of Its Billings in Play

Biogénesis Bagó opens offices in Vietnam, strengthening its presence in Asia

Dec 4, 2024

After years of commitment to animal health in the Asian market providing high-quality biotechnological solutions,this significant milestone further strengthens the company\'s long-term expansion stra

ShiraTronics Initiates IDE Pivotal Study of Implantable Neuromodulation Therapy for Chronic Migraine

Dec 4, 2024

First Implants of Innovative Device Completed in the United States and Australia MINNEAPOLIS,Dec. 3,2024--ShiraTronics,a clinical-stage innovator in neuromodulation technology,today announced the ini

VivaVision Announces Positive Topline Results from Phase 2 Trial of VVN461 for Post-Operative Inflammation Following Cataract Surgery

Dec 4, 2024

VVN461,a non-steroidal dual JAK1/TYK2 immunomodulator,achieves primary endpoint,demonstrating statistical and clinical efficacy compared to vehicle in treatingpost-operative inflammation following cat

1 ... 679 680 681 682 683 684 685 ... 1246